FFIV vs FGEN · P/E 32, rev $3.09B vs rev $29.6M
F5 Networks Inc (FFIV) versus FibroGen Inc (FGEN) — a side-by-side from cached financials, not a winner call.
F5 Networks Inc (FFIV) is a software - infrastructure company listed on NASDAQ.
FibroGen Inc (FGEN) is a biotechnology company listed on NASDAQ.
Latest reported FFIV revenue for 2025-09-30 was $3.09B. Net income was $692.4M. FFIV currently screens at market cap $21.71B and trailing P/E 31.6.
Latest reported FGEN revenue for 2024-12-31 was $29.6M. Net income was -$47.6M. Revenue was down 36.7% from 2023-12-31 to 2024-12-31. FGEN currently screens at market cap $39.3M.
FFIV currently screens at market cap $21.71B and trailing P/E 31.6. FGEN currently screens at market cap $39.3M.
Not investment advice. Open the FFIV and FGEN stock pages for the full models.
Not investment advice.